SPY314.07+3.55 1.14%
DIA260.11+2.80 1.09%
IXIC10,271.64+117.01 1.15%

Neoleukin Therapeutics Q3 EPS $(2.26) Down From $(0.64) YoY

Neoleukin Therapeutics (NASDAQ:NLTX) reported quarterly losses of $(2.26) per share. This is a 253.12 percent decrease over losses of $(0.64) per share from the same period last year.

Benzinga · -

Neoleukin Therapeutics (NASDAQ:NLTX) reported quarterly losses of $(2.26) per share. This is a 253.12 percent decrease over losses of $(0.64) per share from the same period last year.